Medical radionuclide / Radionuclides Y-88, Zr-89, Zr-88 / Excitation function / Cross section / Integral yield Summary. Excitation functions of the reactions 89 Y( p, n) 89 Zr, 89 Y( p, 2n) 88 Zr and 89 Y( p, pn) 88 Y were measured from their respective thresholds up to 17.7 MeV, with particular emphasis on data for the production of the medically important radionuclide 89 Zr. The conventional stacked-foil technique was used, and the samples for irradiation were prepared by the sedimentation process. The excitation functions obtained were compared with those calculated theoretically using the ALICE-IPPE code. The measured data were also compared with the available literature values. From the experimental data the theoretical yields of the investigated radionuclides were calculated as a function of proton energy. The excitation function for the 89 Y( p, n) 89 Zr reaction measured in the proton energy range 5.1 to 17.7 MeV shows a pronounced broad peak in the energy range 16 → 11 MeV. On the other hand and because of the high threshold energy of the two other reactions 89 Y( p, 2n) 88 Zr and 89 Y( p, pn) 88 Y, their excitation functions were measured only in the proton energy range 14.3 to 17.7 MeV. Differential and integral yields for the production of the three radionuclides were calculated. It was found that the suitable energy range for the production of 89 Zr is 14 → 9 MeV; over this energy range the 89 Zr amounts to 58 MBq/µA h. In the proton energy range provided by MGC-20 cyclotron [E p (max) = 18 MeV], only 89 Zr can be produced in a suitable activity and with a high purity. Production of 88 Zr and 88 Y needs proton energy higher than that provided by this type of cyclotron.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.